B-cell lymphoma

From WikiMD's Medical Encyclopedia

Revision as of 15:16, 28 June 2023 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

B-cell lymphoma
Synonyms
Pronounce
Field Hematology, oncology
Symptoms
Complications
Onset
Duration
Types
Causes
Risks
Diagnosis
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths


The B-cell lymphomas are types of lymphoma affecting B cells. Lymphomas are "blood cancers" in the lymph nodes. They develop more frequently in older adults and in immunocompromised individuals.

B-cell lymphomas include both Hodgkin's lymphomas and most non-Hodgkin lymphomas. They are typically divided into low and high grade, typically corresponding to indolent (slow-growing) lymphomas and aggressive lymphomas, respectively. As a generalisation, indolent lymphomas respond to treatment and are kept under control (in remission) with long-term survival of many years, but are not cured. Aggressive lymphomas usually require intensive treatments, with some having a good prospect for a permanent cure.<ref name="mmhe">Merck Manual home edition, Non-Hodgkin Lymphomas</ref>

Prognosis and treatment depends on the specific type of lymphoma as well as the stage and grade. Treatment includes radiation and chemotherapy. Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence. Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.<ref name="mmhe"/> Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress. Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.<ref name="mmhe"/>

Types

Micrograph showing Hodgkin's lymphoma, a type of B cell lymphoma that is usually considered separate from other B cell lymphomas. Field stain.
CT scan of primary B cell lymphoma in the left ilium, as diffuse cortical and trabecular thickening of the hemipelvis, mimicking Paget's disease.<ref>, Primary B-cell lymphoma of the pelvic bone in a young patient: Imaging features of a rare case, Cancer Research Frontiers, 2017, Vol. 3(Issue: 1), pp. 51–55, DOI: 10.17980/2017.51,</ref>

There are numerous kinds of lymphomas involving B cells. The most commonly used classification system is the WHO classification, a convergence of more than one, older classification systems.

Common

Five account for nearly three out of four patients with non-Hodgkin lymphoma:<ref name="The Lymphomas">

The Lymphomas(link). {{{website}}}. The Leukemia & Lymphoma Society. May 2006.



</ref> 

 B-Cell Lymphoma of the Thoracic Spine Presenting with Spinal Cord Pressure Syndrome, 
 Journal of Clinical Medicine Research, 
 2010,
 Vol. 2(Issue: 1),
 pp. 53–54,
 DOI: 10.4021/jocmr2010.02.258w,
 PMID: 22457704,
 PMC: 3299178,</ref>

Rare

The remaining forms are much less common:<ref name="The Lymphomas"/>

Other

Additionally, some researchers separate out lymphomas that appear to result from other immune system disorders, such as AIDS-related lymphoma.

Classic Hodgkin's lymphoma and nodular lymphocyte predominant Hodgkin's lymphoma are now considered forms of B-cell lymphoma.<ref name="urlHMDS: Hodgkins Lymphoma">

HMDS: Hodgkin's Lymphoma(link). {{{website}}}.




</ref>

Associated chromosomal translocations

Chromosomal translocations involving the immunoglobulin heavy locus (IGH@) is a classic cytogenetic abnormality for many B-cell lymphomas, including follicular lymphoma, mantle cell lymphoma and Burkitt's lymphoma. In these cases, the immunoglobulin heavy locus forms a fusion protein with another protein that has pro-proliferative or anti-apoptotic abilities. The enhancer element of the immunoglobulin heavy locus, which normally functions to make B cells produce massive production of antibodies, now induces massive transcription of the fusion protein, resulting in excessive pro-proliferative or anti-apoptotic effects on the B cells containing the fusion protein.

In Burkitt's lymphoma and mantle cell lymphoma, the other protein in the fusion is c-myc (on chromosome 8) and cyclin D1<ref name=jy>, 

 Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization, 
 Am. J. Pathol., 
 
 Vol. 154(Issue: 5),
 pp. 1449–52,
 DOI: 10.1016/S0002-9440(10)65399-0,
 PMID: 10329598,
 PMC: 1866594,</ref> (on chromosome 11), respectively, which gives the fusion protein pro-proliferative ability. In follicular lymphoma, the fused protein is

Bcl-2 (on chromosome 18), which gives the fusion protein anti-apoptotic abilities.

See also

References

External links

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=B-cell_lymphoma&oldid=4964336"